What one share of Exicure holds
Historically, we have been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. In September 2022, we announced a significant reduction in force, suspension of preclinical activities and halting of all research and development, and that we were exploring strategic alternatives to maximize stockholder value.
Exicure’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.00 |
|---|---|
| Profit | −$1.30 |
| Capex (buildings and equipment) | −$0.05 |
| Free cash flow | −$1.00 |
| Cash and investments | $0.27 |
| Book value | $0.15 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | — | −$163.21 | $13.73 | −$307.05 | — | — |
| 2018 | — | −$81.62 | $0.34 | −$71.31 | — | $70.85 |
| 2019 | — | −$68.41 | $2.81 | $0.61 | — | $140.72 |
| 2020 | — | −$42.43 | $5.45 | −$73.00 | — | $105.26 |
| 2021 | — | −$108.50 | $1.64 | −$60.58 | — | $15.49 |
| 2022 | — | −$2.79 | $0.01 | −$38.61 | — | $15.02 |
| 2023 | — | −$10.55 | $0.00 | −$6.46 | — | $1.65 |
| 2024 | $0.24 | −$4.75 | $0.00 | −$1.42 | — | — |
| 2025 | $0.00 | −$0.79 | $0.00 | −$1.36 | — | $0.62 |
Common questions about Exicure
How much does one share of Exicure earn?
Over the last 12 months, Exicure lost $1.30 for each share.
Does Exicure pay a dividend?
Exicure didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Exicure’s book value per share?
Exicure’s book value is $0.15 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Exicure have?
Each share of Exicure has $0.27 of cash and investments, as of June 30, 2026.
What is Exicure’s free cash flow per share?
−$1.00 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Exicure bought back shares?
Exicure’s share count rose about 9234% from 2017 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.